Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2013

Singh C, Jessurun J, H Gulbahce E, Pambuccian SE. Fine-needle aspiration diagnosis of metastatic intestinal-type sinonasal adenocarcinoma. Diagn Cytopathol. 2013;41(2):153-8.

2012

Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, et al. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc Natl Acad Sci U S A. 2012;109(28):11252-7.

Howan K, Smith AJ, Westblade LF, Joly N, Grange W, Zorman S, et al. Initiation of transcription-coupled repair characterized at single-molecule resolution. Nature. 2012;490(7420):431-4.

Durand M, Robinson BD, Aronowitz E, Tewari AK, Ballon DJ. High-resolution magnetic resonance imaging of prostatectomy specimens: a promising tool for virtual histology. Eur Urol. 2012;62(5):938-40.

Samstein RM, Arvey A, Josefowicz SZ, Peng X, Reynolds A, Sandstrom R, et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell. 2012;151(1):153-66.

Gianoulis TA, Griffin MA, Spakowicz DJ, Dunican BF, Alpha CJ, Sboner A, et al. Genomic analysis of the hydrocarbon-producing, cellulolytic, endophytic fungus Ascocoryne sarcoides. PLoS Genet. 2012;8(3):e1002558.

Greenblatt MB, Sargent JL, Farina G, Tsang K, Lafyatis R, Glimcher LH, et al. Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets. Am J Pathol. 2012;180(3):1080-1094.

Vang R, Gupta M, Wu L-, Yemelyanova AV, Kurman RJ, Murphy KM, et al. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis. Am J Surg Pathol. 2012;36(3):443-53.

Usubutun A, Mutter GL, Saglam A, Dolgun A, Ozkan EA, Ince T, et al. Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists. Mod Pathol. 2012;25(6):877-84.

Benassi B, Flavin R, Marchionni L, Zanata S, Pan Y, Chowdhury D, et al. MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. Cancer Discov. 2012;2(3):236-47.